Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3763466014 | Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3763467017 | Drospirenone 3 mg and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3763468010 | Drospirenone 3 mg and ethinyl estradiol 20 microgram and levomefolate calcium 451 microgram oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing drospirenone and ethinylestradiol | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing estradiol in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Ethinylestradiol | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Drospirenone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Levomefolate calcium | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing levomefolic acid (medicinal product) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing drospirenone and ethinylestradiol in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Ethinylestradiol | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Ethinylestradiol | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 3 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 20 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Plays role | Contraceptive therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing only drospirenone and ethinylestradiol and levomefolic acid in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 3 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Levomefolate calcium | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 451 | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Levomefolate calcium | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Drospirenone | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Drospirenone | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 3 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR